Virbac SA (EPA:VIRP)
France · Delayed Price · Currency is EUR 321.00
-1.50 (-0.47%)
Sep 3, 2026, 5:35 PM CET
Virbac Market Cap
Virbac has a market cap or net worth of €2.69 billion as of September 3, 2026. Its market cap has decreased by -1.80% in one year.
Market Cap
2.69B
Enterprise Value
2.85B
Revenue
1.46B
Ranking
n/a
PE Ratio
17.83
Stock Price
€321.00
ChartMarket Cap Chart
Since August 8, 1994, Virbac's market cap has increased from 217.52M to 2.69B, an increase of 1,136.34%. That is a compound annual growth rate of 8.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2026 | 2.69B | -10.21% |
| Dec 31, 2025 | 3.00B | 13.00% |
| Dec 31, 2024 | 2.65B | -12.68% |
| Dec 29, 2023 | 3.04B | 57.52% |
| Dec 30, 2022 | 1.93B | -46.24% |
| Dec 31, 2021 | 3.58B | 78.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sanofi | 92.44B |
| EssilorLuxottica Société anonyme | 73.33B |
| Sartorius Stedim Biotech | 19.25B |
| Ipsen | 13.75B |
| bioMérieux | 8.90B |
| emeis Société anonyme | 2.04B |
| Nanobiotix | 1.70B |
| Clariane SE | 1.39B |